MedPath

Improvement of high-normal blood pressure by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial

Phase 1
Recruiting
Conditions
High-normal blood pressure
Registration Number
ITMCTR1900002508
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meeting the high-normal blood pressure criteria;
2. Aged 35–65 years, male of female;
3. No language and mental retardation, able to answer and complete the questionnaire smoothly;
4. Participants or their guardian willing to sign written informed consent.

Exclusion Criteria

1. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors;cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; scars, bruises, scratches or inflammation on the skin of the acupuncture points.
2. Hypertension caused by other vascular diseases, primary aldosteronism, other endocrine hypertension, and secondary hypertension caused by other causes.
3. Receiving antihypertensive drugs or other drugs that affect blood pressure in previous 2 months.
4. Uncontrolled diabetes.
5. Receiving acupuncture treatment in previous 1 month.
6. Drug or alcohol abuse.
7. Pregnant women or women in lactation period.
8. Joined any other study in process.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the differences in mean systolic pressure changes;
Secondary Outcome Measures
NameTimeMethod
Proportion of progression to hypertension;Quality of life evaluation;International Physical Activity Questionnaire;Weight, body mass index and waist circumference;the differences in mean diastolic blood pressure changes;
© Copyright 2025. All Rights Reserved by MedPath